FAST IDENTIFICATION OF PATHOGENS

 

MariPoc system

maripoc sistema arcdia somija

What is the mariPOC® test system?

  • A new point-of-care test system for acute infections
  • First test system in the market for multianalyte POC testing
  • Automated random-access antigen detection test
  • For respiratory (swab, aspirate) and stool samples
  • IVD-CE marked

Why to choose mariPOC® for acute infection diagnostics?

  • Accuracy similar to central laboratory antigen tests
  • Easy-to-use and short hands-on-time. The first result available in 20 minutes
  • Automated results read-out
  • Replaces conventional rapid and laboratory antigen tests
  • Can be connected to laboratory information systems

What does the mariPOC® test system allow?

  • Pathogen-specific diagnosis on time
  • Accurate use of virus-specific drugs and antimicrobials
  • In-patient cohorting
  • Efficient control of patient flow
  • Improved cost-effectiveness

MariAST system

ArcDia’s mariAST® is the most promising platform to tackle antibiotic resistance.

  • Allows testing of antibiotic resistance directly from polymicrobial clinical samples
  • Is rapid and easy to use
  • Is fully automated
  • Has a high capacity: 40 -100 samples per day
  • Enables bringing AST and resistance testing in a point-of-care environment

mariAST® measures species-specific bacterial growth in real-time. mariAST® combines in-well culture and high-accuracy bacterial detection. The process yields an ID in only 20 minutes, and reports resistance results for strong positive inoculum in just 2 hours after sampling.

Pre-treatment

ArcDia’s mariAST® is based on ArcDia’s mariPOC® field-proven test system.

ArcDia’s platform:

  • Is based on the proprietary TPX detection tecnology published in Nature Biotechnology in 2000
  • Has been deployed in routine central lab and point-of-care settings since 2011
  • Has been awarded e.g. Frost & Sullivan Point-of-Care Leadership Prize in 2014
  • Whose sister technology, born and developed in ArcDia’s scientific founder’s lab in Finland, won The Nobel Prize in Chemistry in 2014

Our company

DIAMEDICA Latvia belongs to the DIAMEDICA OU Group, which was founded in 1991 and is owned by Baltic originated private capital. DIAMEDICA Group operates in all three Baltic countries (Estonia, Latvia and Lithuania) and has its representative offices in Tallinn, Riga and Vilnius.

DIAMEDICA Latvia actively operates since the end of 1993. DIAMEDICA operates in the field of clinical laboratory equipment, which includes distribution of analyzers, reagents and microscopes as well as hardware maintenance services. During last year’s company has expanded its operations also to hospital equipment and environmental laboratories.

ISO 9001:2015

Since 26.11.2012. Ltd. Diamedica management system is certified according to international standard ISO 9001.

ISO 9001 serifikats LVmin

 

Spheres of activity

Privacy Policy

Our contacts

  This email address is being protected from spambots. You need JavaScript enabled to view it.
  +371 67577833
  +371 67578270
Augusta Deglava street 66, Riga, LV-1035

Our Map